A detailed history of Clearbridge Investments, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 74,387 shares of AMGN stock, worth $19.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
74,387
Previous 76,046 2.18%
Holding current value
$19.6 Million
Previous $23.8 Million 0.88%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $513,261 - $559,713
-1,659 Reduced 2.18%
74,387 $24 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $246,722 - $299,832
-939 Reduced 1.22%
76,046 $23.8 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $7.03 Million - $8.48 Million
-26,132 Reduced 25.34%
76,985 $21.9 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $652,546 - $736,149
2,552 Added 2.54%
103,117 $29.7 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $359,023 - $445,737
-1,642 Reduced 1.61%
100,565 $27 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $70 Million - $82.8 Million
-326,611 Reduced 76.17%
102,207 $22.7 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $749,171 - $913,113
-3,318 Reduced 0.77%
428,818 $104 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $1.13 Million - $1.44 Million
-4,936 Reduced 1.13%
432,136 $113 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $876,291 - $988,297
3,904 Added 0.9%
437,072 $98.5 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $255,626 - $284,467
-1,108 Reduced 0.26%
433,168 $105 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $1.65 Million - $1.83 Million
-7,545 Reduced 1.71%
434,276 $105 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $184 Million - $210 Million
-923,771 Reduced 67.65%
441,821 $99.4 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $727 Million - $851 Million
-3,423,540 Reduced 71.49%
1,365,592 $290 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $233 Million - $259 Million
-998,101 Reduced 17.25%
4,789,132 $1.17 Billion
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $3.63 Million - $4.23 Million
16,353 Added 0.28%
5,787,233 $1.44 Billion
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $33.6 Million - $40 Million
-155,218 Reduced 2.62%
5,770,880 $1.33 Billion
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $63.6 Million - $70.8 Million
271,144 Added 4.79%
5,926,098 $1.51 Billion
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $304 Million - $373 Million
1,536,197 Added 37.3%
5,654,954 $1.33 Billion
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $452 Million - $599 Million
2,478,922 Added 151.17%
4,118,757 $835 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $138 Million - $178 Million
-731,550 Reduced 30.85%
1,639,835 $394 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $6.56 Million - $7.86 Million
-37,686 Reduced 1.56%
2,371,385 $459 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $84.3 Million - $98.8 Million
-505,714 Reduced 17.35%
2,409,071 $0
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $62.2 Million - $70.1 Million
-343,685 Reduced 10.55%
2,914,785 $554 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $129 Million - $151 Million
-722,730 Reduced 18.15%
3,258,470 $634 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $172 Million - $194 Million
-928,648 Reduced 18.91%
3,981,200 $825 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $165 Million - $186 Million
-995,725 Reduced 16.86%
4,909,848 $906 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $264 Million - $308 Million
-1,557,916 Reduced 20.87%
5,905,573 $1.01 Billion
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $74.9 Million - $83.7 Million
-443,610 Reduced 5.61%
7,463,489 $1.3 Billion
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $103 Million - $117 Million
-614,390 Reduced 7.21%
7,907,099 $1.47 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
8,521,489
8,521,489 $1.47 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.